{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T01:46:37Z","timestamp":1770515197862,"version":"3.49.0"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001700","name":"Ministry of Education, Culture, Sports, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001700","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","internationaljournalofcardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ijcard.2019.09.057","type":"journal-article","created":{"date-parts":[[2019,10,8]],"date-time":"2019-10-08T11:10:37Z","timestamp":1570533037000},"page":"8-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia"],"prefix":"10.1016","volume":"297","author":[{"given":"Yoku","family":"Kikuchi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kiyotaka","family":"Hao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Sugisawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Tsuchiya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Suda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiko","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shohei","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Shiroto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuharu","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Miyata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuhiko","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroaki","family":"Shimokawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2019.09.057_bib1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/j.jacc.2007.06.022","article-title":"Coronary revascularization in the community. A population-based study, 1990 to 2004","volume":"50","author":"Gerber","year":"2007","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib2","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.jacc.2016.12.005","article-title":"Trends in U.S. Cardiovascular care: 2016 report from 4 ACC national cardiovascular data registries","volume":"69","author":"Masoudi","year":"2017","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJMra0912134","article-title":"Myocardial infarction due to percutaneous coronary intervention","volume":"364","author":"Prasad","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.09.057_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0735-1097(00)00865-2","article-title":"Angiographic no-reflow phenomenon as a predictor of adverse long-term outcome in patients treated with percutaneous transluminal coronary angioplasty for first acute myocardial infarction","volume":"36","author":"Morishima","year":"2000","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib5","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/j.jacc.2009.12.054","article-title":"5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction","volume":"55","author":"Ndrepepa","year":"2010","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/MCA.0000000000000443","article-title":"Coronary microvascular dysfunction in acute ST elevation myocardial infarction","volume":"28","author":"Beltrame","year":"2017","journal-title":"Coron. Artery Dis."},{"key":"10.1016\/j.ijcard.2019.09.057_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/eurheartj\/ehy462","article-title":"ESC Scientific Document Group. Fourth universal definition of myocardial infarction (2018)","volume":"40","author":"Thygesen","year":"2019","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib8","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1093\/eurheartj\/ehx799","article-title":"Periprocedural myocardial infarction and injury in elective coronary stenting","volume":"39","author":"Zeitouni","year":"2018","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib9","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jacc.2006.04.102","article-title":"Isolated elevation in troponin T after percutaneous coronary intervention is associated with high long-term mortality","volume":"48","author":"Prasad","year":"2006","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib10","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jcin.2016.11.059","article-title":"Management of no-reflow phenomenon in the catheterization laboratory","volume":"10","author":"Rezkalla","year":"2017","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.ijcard.2019.09.057_bib11","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1093\/eurheartj\/ehq299","article-title":"No-reflow: again prevention is better than treatment","volume":"31","author":"Niccoli","year":"2010","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib12","doi-asserted-by":"crossref","first-page":"E15","DOI":"10.1016\/j.ahj.2004.05.014","article-title":"Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation","volume":"148","author":"Ono","year":"2004","journal-title":"Am. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib13","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1016\/S0140-6736(07)61634-1","article-title":"Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials","volume":"370","author":"Kitakaze","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2019.09.057_bib14","doi-asserted-by":"crossref","first-page":"3180","DOI":"10.1093\/eurheartj\/ehu427","article-title":"Williams Harvey Lecture: importance of coronary vasomotion abnormalities-from bench to bedside","volume":"35","author":"Shimokawa","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib15","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1161\/hc1002.105938","article-title":"Suppression of coronary artery spasm by the Rho-kinase inhibitor fasudil in patients with vasospastic angina","volume":"105","author":"Masumoto","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.09.057_bib16","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0735-1097(02)02632-3","article-title":"Rho-kinase inhibition with intracoronary fasudil prevents myocardial ischemia in patients with coronary microvascular spasm","volume":"41","author":"Mohri","year":"2003","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib17","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s12928-011-0071-2","article-title":"The impact of Rho-kinase inhibitor, \u201cFasudil\u201d, intracoronary bolus administration to improve refractory coronary vasospasm","volume":"26","author":"Komiyama","year":"2011","journal-title":"Cardiovasc Interv Ther"},{"key":"10.1016\/j.ijcard.2019.09.057_bib18","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1161\/01.CIR.0000034670.06526.15","volume":"106","author":"Gibbons","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.09.057_bib19","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1253\/circj.CJ-66-0098","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (Coronary Spastic Angina) (JCS 2013)","volume":"78","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib20","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1253\/circj.CJ-13-1482","article-title":"Efficacy and safety of adjusted-dose prasugrel compared with clopidogrel in Japanese patients with acute coronary syndrome: the PRASFIT-ACS study","volume":"78","author":"Saito","year":"2014","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib21","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJM198504043121437","article-title":"The thrombolysis in myocardial infarction (TIMI) trial. Phase I findings","volume":"312","year":"1985","journal-title":"N.\u00a0Engl. J. Med."},{"key":"10.1016\/j.ijcard.2019.09.057_bib22","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1161\/01.CIR.93.5.879","article-title":"TIMI frame count: a quantitative method of assessing coronary artery flow","volume":"93","author":"Gibson","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2019.09.057_bib23","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1016\/j.jcin.2010.01.015","article-title":"Impact of ultrasound attenuation and plaque rupture as detected by intravascular ultrasound on the incidence of no-reflow phenomenon after percuaneous coronary intervention in ST-segment elevation myocardial infarction","volume":"3","author":"Endo","year":"2010","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.ijcard.2019.09.057_bib24","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1016\/S0735-1097(01)01175-5","volume":"37","author":"Mintz","year":"2001","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib25","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1016\/j.jcin.2015.01.032","volume":"8","author":"Stone","year":"2015","journal-title":"J\u00a0Am Coll Cardiol Intv"},{"key":"10.1016\/j.ijcard.2019.09.057_bib26","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0735-1097(02)02014-4","article-title":"Effect of additional temporary glycoprotein IIb\/IIIa receptor inhibition on troponin release in elective percutaneous coronary interventions after pretreatment with aspirin and clopidogrel (TOPSTAR trial)","volume":"40","author":"Bonz","year":"2002","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.amjcard.2003.11.070","article-title":"Predictors of troponin elevation after percutaneous coronary intervention","volume":"93","author":"Mandadi","year":"2004","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib28","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1016\/j.amjcard.2005.12.050","article-title":"REPLACE-2 Investigators. Angiographic adverse events, creatine kinase-MB elevation, and ischemic end points complicating percutaneous coronary intervention (a REPLACE-2 substudy)","volume":"97","author":"Blankenship","year":"2006","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib29","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjcard.2006.09.108","article-title":"Predictors of periprocedural creatine kinase-myocardial band elevation complicating elective percutaneous coronary intervention","volume":"99","author":"Cai","year":"2007","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.ijcard.2008.03.033","article-title":"The Syntax score predicts peri-procedural myocardial necrosis during percutaneous coronary intervention","volume":"135","author":"Van Gaal","year":"2009","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2019.09.057_bib31","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1161\/CIRCINTERVENTIONS.110.959080","article-title":"Periprocedural myocardial infarction. Prevalence, prognosis, and prevention","volume":"3","author":"Lansky","year":"2010","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.ijcard.2019.09.057_bib32","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.1253\/circj.CJ-12-0662","article-title":"Involvement of Rho-kinase activation in the pathogenesis of coronary hyperconstricting responses induced by drug-eluting stents in patients with coronary artery disease","volume":"76","author":"Aizawa","year":"2012","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib33","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1093\/eurheartj\/ehr145","article-title":"Long-term treatment with nifedipine suppresses coronary hyperconstricting responses and inflammatory changes induced by paclitaxel-eluting stent in pigs in\u00a0vivo: possible involvement of Rho-kinase pathway","volume":"33","author":"Tsuburaya","year":"2012","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2019.09.057_bib34","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/j.jacc.2004.10.053","article-title":"Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia\/reperfusion injury in canine coronary microcirculation in\u00a0vivo","volume":"45","author":"Yada","year":"2005","journal-title":"J.\u00a0Am. Coll. Cardiol."}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319332012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0167527319332012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T20:44:05Z","timestamp":1759092245000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0167527319332012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":34,"alternative-id":["S0167527319332012"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.057","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Usefulness of intracoronary administration of fasudil, a selective Rho-kinase inhibitor, for PCI-related refractory myocardial ischemia","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2019.09.057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}